Becoming the "partner of choice" goes well beyond just providing a pill or device for treatment. It requires a cohesive, integrated care approach to disease management from prevention to early interception, diagnosis to treatment sequencing and compliance to effectiveness. In a financially-driven environment where outcomes-based reimbursement models are becoming commonplace and newly-empowered patient populations are demanding more of companies to support their health and well-being, innovation must focus on addressing unmet, under-addressed or hidden needs that extend beyond pharmacology.

Enter Signals Analytics, creator of the only cloud-based system of insight that transforms the world’s unconnected data and real world evidence into actionable intelligence to enhance therapeutic outcomes, optimize product portfolio health and propel patient-centered innovation. By utilizing Signals Playbook, life sciences innovators can discern the combination of diagnostics, treatments, technologies and services that can satisfy the holistic requirements of the patient, assure adherence and result in better therapeutic effectiveness.


Signals empowers us to quickly grow our portfolio through ongoing monitoring of our potential licensing partners, acquisition targets and technology alliances.”

Global R&D Commercial Strategy Head at a Top 5 Consumer Healthcare Company

Impact to Your Business


Discover Unmet Disease Prevention, Treatment and Management Needs of Patients and Providers 

Uncover White Space and Opportunity Horizons for Digital "Beyond the Pill" Patient-Centric Services 

Explore Competitor Movements in Response to Emerging Disease States, Treatment Sequences and Therapeutic Devleopments

Utilize Patient, Healthcare Provider, Payor, Regulator and Public Sentiment to Create "Whole Product" Therapies

Analyze Buy, Build or Partner Scenarios for Horizontal Integration and Quicker Market Entry


A Top 10 Global Life Sciences Company Grows
Its Product Portfolio and Optimizes R&D Costs

A top 10 global pharmaceutical company was actively engaging in buy, build or partner analysis to augment its late-stage pipeline and avoid the costs of developing a “beyond the pill” solution. Within 4 weeks, Signals Playbook identified, evaluated and ranked 30 potential M&A targets that fit the client’s business objectives.

The Signals Analytics Difference


Precision Intelligence That Matters Most to Your Enterprise

Real Time Signals Detection with Validated Source Data  

Built By Industry Experts For Industry Experts

Rapid Business Impact and Value Right
Out of the

Learning Combined with Human Intelligence


The Latest From Signals Analytics

Let's Talk


Signals Analytics Headquarters
1325 Avenue of the Americas, 25th Floor
New York, NY 10019
(917) 470 9110

Signals Analytics Labs
7 Giborei Israel St.
P.O.B 8374, Netanya 4250407, Israel
+972 73 718 1650

Signals Analytics Europe
Av. de Sécheron 15,
1202 Geneva, Switzerland
+41 22 575 5045

All Offices




General Information:

Inquires or Request a Demo